Release Date: 27/02/15 08:50 Summary: 99 Wuxian delivers significant revenue and profit growth Price Sensitive: No Download Document 167.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%